marketcaparena
Search

    WGS

    GeneDx Holdings Corp.

    Company overview

    Market capitalization
    $2.56B
    Employees
    1,300
    Latest publication
    2026-09-29
    About GeneDx Holdings Corp.

    GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ2 20252025-06-30 · USDQ4 20242024-12-31 · USD
    Total Revenue114,440,000USD102,692,000USD95,640,000USD
    Cost Of Revenue36,202,000USD31,790,000USD29,435,000USD
    Gross Profit78,238,000USD70,902,000USD66,205,000USD
    Research Development19,656,000USD14,870,000USD11,588,000USD
    Selling General Administrative76,037,000USD26,936,000USD27,350,000USD
    Total Operating Expenses95,693,000USD61,942,000USD57,399,000USD
    Operating Income-17,455,000USD8,960,000USD8,806,000USD
    Total Other Income Expense Net-803,000USD1,603,000USD-3,392,000USD
    Income Before Tax-18,258,000USD10,563,000USD5,414,000USD
    Income Tax Expense-518,000USD-246,000USD-24,000USD
    Net Income-17,740,000USD10,809,000USD5,438,000USD
    Selling And Marketing Expenses—19,448,000USD17,676,000USD
    Interest Expense—817,000USD698,000USD
    Net Interest Income—-817,000USD-698,000USD
    Tax Provision—-246,000USD-24,000USD
    Net Income From Continuing Ops—10,809,000USD5,438,000USD
    Ebit—11,380,000USD6,112,000USD
    Ebitda—17,571,000USD11,670,000USD
    Depreciation And Amortization—6,191,000USD5,558,000USD
    Reconciled Depreciation—6,191,000USD5,558,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets481,486,000USD506,301,000USD570,190,000USD493,902,000USD463,863,000USD446,430,000USD419,380,000USD408,840,000USD
    Cash And Equivalents60,317,000USD———————
    Cash And Short Term Investments132,548,000USD170,685,000USD171,282,000USD155,079,000USD134,558,000USD159,160,000USD141,185,000USD116,460,000USD
    Short Term Investments72,231,000USD76,761,000USD66,285,000USD59,111,000USD60,438,000USD59,456,000USD55,973,000USD58,566,000USD
    Total Current Assets246,360,000USD270,629,000USD268,288,000USD237,583,000USD204,837,000USD225,816,000USD197,968,000USD186,010,000USD
    Other Current Assets12,382,000USD10,774,000USD8,685,000USD10,997,000USD10,319,000USD7,935,000USD8,504,000USD20,300,000USD
    Other Non Current Assets4,284,000USD———————
    Total Liabilities237,265,000USD———————
    Total Current Liabilities74,628,000USD87,639,000USD108,908,000USD87,621,000USD71,406,000USD69,541,000USD54,817,000USD77,342,000USD
    Other Current Liabilities26,828,000USD———————
    Other Non Current Liabilities71,000USD———————
    Total Stockholder Equity244,221,000USD254,124,000USD308,182,000USD292,258,000USD277,133,000USD257,405,000USD245,247,000USD204,501,000USD
    Total Equity Including Noncontrolling Interest244,221,000USD———————
    Long Term Debt96,836,000USD96,732,000USD48,176,000USD51,579,000USD51,683,000USD51,794,000USD51,913,000USD52,034,000USD
    Net Receivables83,610,000USD76,929,000USD74,370,000USD60,938,000USD48,028,000USD46,059,000USD37,629,000USD38,480,000USD
    Inventory17,820,000USD12,241,000USD13,951,000USD10,569,000USD11,932,000USD12,662,000USD10,650,000USD10,770,000USD
    Property Plant Equipment Net87,851,000USD84,778,000USD69,105,000USD66,622,000USD65,098,000USD61,266,000USD58,506,000USD56,388,000USD
    Goodwill1,641,000USD———————
    Intangible Assets141,350,000USD144,969,000USD168,481,000USD172,585,000USD176,689,000USD155,094,000USD158,600,000USD162,106,000USD
    Accounts Payable42,091,000USD11,168,000USD2,461,000USD2,630,000USD3,522,000USD15,856,000USD7,954,000USD9,022,000USD
    Common Stock3,000USD3,000USD3,000USD2,000USD2,000USD2,000USD2,000USD2,000USD
    Retained Earnings-1,454,551,000USD-1,436,811,000USD-1,373,495,000USD-1,355,829,000USD-1,348,194,000USD-1,359,003,000USD-1,352,474,000USD-1,357,912,000USD
    Accumulated Other Comprehensive Income342,000USD683,000USD936,000USD1,002,000USD812,000USD905,000USD830,000USD918,000USD
    Total Liab—252,177,000USD262,007,999USD201,644,000USD186,730,000USD189,025,000USD174,133,000USD204,339,000USD
    Other Current Liab—71,342,000USD97,501,000USD80,562,000USD64,801,000USD69,541,000USD43,527,000USD64,622,000USD
    Capital Stock—3,000USD3,000USD2,000USD2,000USD2,000USD2,000USD2,000USD
    Good Will—1,641,000USD13,520,000USD12,798,000USD12,926,000USD—0USD—
    Cash—93,924,000USD104,997,000USD95,968,000USD74,120,000USD99,704,000USD85,212,000USD57,894,000USD
    Net Debt—74,268,000USD46,949,000USD17,193,000USD40,265,000USD-43,110,000USD30,956,000USD58,207,000USD
    Short Term Debt—5,129,000USD8,946,000USD4,429,000USD3,083,000USD3,124,000USD3,336,000USD3,698,000USD
    Short Long Term Debt Total—168,192,000USD151,946,000USD113,161,000USD114,385,000USD114,836,000USD116,168,000USD116,101,000USD
    Property Plant Equipment Gross—113,067,000USD94,622,000USD91,262,000USD87,933,000USD83,522,000USD110,984,000USD106,962,000USD
    Common Stock Shares Outstanding—29,335,126shares26,891,213shares28,797,730shares29,753,933shares28,147,948shares26,993,600shares27,095,986shares
    Non Current Assets Total—235,672,000USD301,902,000USD256,319,000USD259,026,000USD220,614,000USD221,412,000USD222,830,000USD
    Non Current Liabilities Total—164,538,000USD153,099,999USD114,023,000USD115,324,000USD119,484,000USD119,316,000USD126,997,000USD
    Non Current Liabilities Other—71,000USD1,641,000USD1,839,000USD1,736,000USD———
    Non Currrent Assets Other—4,284,000USD3,324,000USD4,314,000USD4,313,000USD4,254,000USD4,306,000USD3,349,000USD
    Net Working Capital—182,990,000USD159,380,000USD149,962,000USD133,431,000USD156,275,000USD143,151,000USD108,668,000USD
    Unclassified Non Current Liabilities—67,735,000USD103,282,999USD60,605,000USD61,905,000USD67,690,000USD67,403,000USD74,963,000USD
    Unclassified Equity—1,690,246,000USD1,680,735,000USD1,647,081,000USD1,624,511,000USD1,615,499,000USD1,596,887,000USD1,561,491,000USD
    Short Long Term Debt——4,542,000USD———1,211,000USD—
    Unclassified Non Current Assets——47,472,000USD—————
    Unclassified Current Liabilities——-4,542,000USD——-18,980,000USD-1,211,000USD—
    Current Deferred Revenue———————-9,022,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets570,190,000USD419,380,000USD418,756,000USD545,261,000USD554,093,000USD251,642,000USD—
    Intangible Assets168,481,000USD158,600,000USD172,625,000USD186,650,000USD———
    Other Current Assets8,685,000USD8,504,000USD10,598,000USD18,212,000USD22,956,000USD8,681,000USD900,000USD
    Total Liab262,007,999USD174,133,000USD190,739,000USD291,556,000USD165,990,000USD247,254,000USD—
    Total Stockholder Equity308,182,000USD245,247,000USD228,017,000USD253,705,000USD388,103,000USD4,388,000USD—
    Other Current Liab97,501,000USD43,527,000USD44,436,000USD87,369,000USD52,699,000USD41,416,000USD3,062,000USD
    Common Stock3,000USD2,000USD2,000USD38,000USD24,000USD——
    Capital Stock3,000USD2,000USD2,000USD38,000USD24,000USD0USD—
    Retained Earnings-1,373,495,000USD-1,352,474,000USD-1,300,188,000USD-1,124,421,000USD-575,441,000USD-330,051,000USD-88,711,000USD
    Good Will13,520,000USD0USD—————
    Cash104,997,000USD85,212,000USD99,681,000USD137,403,000USD400,569,000USD108,132,000USD—
    Cash And Short Term Investments171,282,000USD141,185,000USD130,148,000USD137,403,000USD400,569,000USD108,132,000USD—
    Total Current Assets268,288,000USD197,968,000USD182,339,000USD212,622,000USD483,544,000USD174,108,000USD163,805,000USD
    Total Current Liabilities108,908,000USD54,817,000USD58,818,000USD144,297,000USD101,284,000USD73,442,000USD40,186,000USD
    Net Debt46,949,000USD30,956,000USD20,089,000USD-60,269,000USD-367,723,000USD-64,877,000USD—
    Short Term Debt8,946,000USD3,336,000USD4,144,000USD10,871,000USD3,419,000USD3,506,000USD—
    Short Long Term Debt4,542,000USD1,211,000USD497,000USD4,750,000USD—1,770,000USD—
    Short Long Term Debt Total151,946,000USD116,168,000USD119,770,000USD77,134,000USD32,846,000USD43,255,000USD—
    Long Term Debt48,176,000USD51,913,000USD52,688,000USD6,250,000USD11,000,000USD18,971,000USD—
    Short Term Investments66,285,000USD55,973,000USD30,467,000USD0USD———
    Net Receivables74,370,000USD37,629,000USD32,816,000USD43,342,000USD26,563,000USD32,333,000USD21,637,000USD
    Inventory13,951,000USD10,650,000USD8,777,000USD13,665,000USD33,456,000USD24,962,000USD15,983,000USD
    Accounts Payable2,461,000USD7,954,000USD10,238,000USD46,017,000USD44,693,000USD26,737,000USD17,475,000USD
    Property Plant Equipment Net69,105,000USD58,506,000USD59,379,000USD84,285,000USD62,719,000USD63,110,000USD35,263,000USD
    Property Plant Equipment Gross94,622,000USD110,984,000USD105,831,000USD84,285,000USD114,625,000USD93,209,000USD—
    Accumulated Other Comprehensive Income936,000USD830,000USD425,000USD————
    Common Stock Shares Outstanding26,891,213shares26,891,213shares24,311,989shares10,236,959shares3,275,073shares5,626,678shares5,626,678shares
    Non Current Assets Total301,902,000USD221,412,000USD236,417,000USD332,638,999USD70,548,999USD77,533,999USD—
    Non Current Liabilities Total153,099,999USD119,316,000USD131,921,000USD147,259,000USD64,706,000USD173,812,000USD—
    Non Current Liabilities Other1,641,000USD——22,000,000USD13,724,000USD2,074,000USD—
    Non Currrent Assets Other3,324,000USD4,306,000USD4,413,000USD6,484,999USD6,929,999USD3,595,999USD—
    Net Working Capital159,380,000USD143,151,000USD123,521,000USD68,325,000USD382,260,000USD100,666,000USD—
    Unclassified Non Current Assets47,472,000USD——47,834,000USD-6,930,000USD-3,596,000USD—
    Unclassified Current Liabilities-4,542,000USD-1,211,000USD—-4,750,000USD—-1,770,000USD19,649,000USD
    Unclassified Non Current Liabilities103,282,999USD67,403,000USD79,233,000USD89,673,000USD-13,724,000USD18,704,000USD—
    Unclassified Equity1,680,735,000USD1,596,887,000USD1,527,776,000USD1,378,050,000USD963,496,000USD334,439,000USD—
    Other Assets——1USD7,385,000USD7,830,000USD14,424,000USD4,771,000USD
    Deferred Long Term Liab———2,659,000USD——200,000USD
    Other Liab———26,677,000USD53,706,000USD134,063,000USD12,973,000USD
    Current Deferred Revenue———40,000USD473,000USD1,783,000USD—
    Net Tangible Assets———253,705,000USD388,103,000USD-330,051,000USD-88,711,000USD
    Unclassified Current Assets——————125,285,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-63,316,000USD-17,666,000USD-7,635,000USD10,809,000USD-6,529,000USD5,438,000USD-8,312,000USD-29,173,000USD
    Depreciation6,809,000USD6,881,000USD6,474,000USD6,191,000USD5,678,000USD-5,608,000USD16,395,000USD5,218,000USD
    Stock Based Compensation8,996,000USD9,780,000USD10,586,000USD7,813,000USD3,983,000USD2,845,000USD3,636,000USD3,108,000USD
    Other Non Cash Items37,368,000USD-1,899,000USD8,967,000USD2,191,000USD3,252,000USD1,927,000USD-10,313,000USD20,079,000USD
    Change To Account Receivables-2,558,000USD-13,432,000USD-12,910,000USD-1,332,000USD-8,557,000USD429,000USD-12,721,000USD2,651,000USD
    Change To Inventory1,689,000USD-3,364,000USD1,332,000USD628,000USD-2,032,000USD-454,000USD-477,000USD1,223,000USD
    Change In Working Capital-23,162,000USD262,000USD-2,871,000USD-16,339,000USD3,351,000USD-7,761,000USD-5,754,000USD-3,547,000USD
    Total Cash From Operating Activities-32,408,000USD-3,090,000USD15,767,000USD10,420,000USD10,182,000USD-3,183,000USD-4,395,000USD-4,505,000USD
    Capital Expenditures-6,453,000USD-4,347,000USD-6,172,000USD-2,369,000USD-6,129,000USD-3,050,000USD-646,000USD-1,352,000USD
    Free Cash Flow-38,861,000USD-7,437,000USD9,595,000USD8,051,000USD4,053,000USD-6,233,000USD-5,041,000USD-5,857,000USD
    Investments-10,802,000USD-7,064,000USD-4,687,000USD-36,350,000USD-9,408,000USD-519,000USD-7,755,000USD-22,701,000USD
    Total Cashflows From Investing Activities-17,255,000USD-11,072,000USD-4,687,000USD-36,350,000USD-9,408,000USD-519,000USD-7,755,000USD-22,701,000USD
    Net Borrowings-58,942,000USD-682,000USD-1,216,000USD-853,000USD-911,000USD-1,528,000USD-707,000USD—
    Total Cash From Financing Activities38,590,000USD23,193,000USD10,768,000USD346,000USD13,718,000USD31,023,000USD13,968,000USD-391,000USD
    Issuance Of Capital Stock97,474,000USD19,874,000USD11,802,000USD1,134,000USD13,894,000USD31,907,000USD14,589,000USD0USD
    Change In Cash-11,073,000USD9,031,000USD21,848,000USD-25,584,000USD14,492,000USD27,321,000USD1,818,000USD-27,597,000USD
    Begin Period Cash Flow105,989,000USD96,958,000USD75,110,000USD100,694,000USD86,202,000USD58,881,000USD57,063,000USD83,673,000USD
    End Period Cash Flow94,916,000USD105,989,000USD96,958,000USD75,110,000USD100,694,000USD86,202,000USD58,881,000USD56,076,000USD
    Other Cashflows From Financing Activities38,590,000USD47,778,000USD182,000USD65,000USD13,718,000USD-2,581,000USD86,000USD137,000USD
    Unclassified Financing Cash Flow-38,532,000USD-43,777,000USD——-12,983,000USD3,225,000USD——
    Other Cashflows From Investing Activities—33,195,000USD-9,408,000USD-33,195,000USD————
    Unclassified Investing Cash Flow—-32,856,000USD15,580,000USD35,564,000USD6,129,000USD3,050,000USD—1,352,000USD
    Sale Purchase Of Stock———1,262,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income-21,021,000USD-52,286,000USD-175,767,000USD-548,980,000USD-245,390,000USD-241,340,000USD-29,704,000USD
    Depreciation25,224,000USD21,953,000USD35,834,000USD59,309,000USD21,807,000USD11,734,000USD6,407,000USD
    Stock Based Compensation32,162,000USD9,138,000USD-326,000USD41,975,000USD219,421,000USD120,231,000USD5,482,000USD
    Other Non Cash Items12,511,000USD17,787,000USD-721,000USD141,534,000USD-194,350,000USD2,400,000USD-176,000USD
    Change To Account Receivables-36,231,000USD-5,421,000USD10,263,000USD5,527,000USD5,535,000USD-10,611,000USD-4,567,000USD
    Change To Inventory-3,436,000USD-2,585,000USD975,000USD4,600,000USD-10,624,000USD-8,979,000USD-7,970,000USD
    Change In Working Capital-15,597,000USD-24,745,000USD-38,241,000USD36,131,000USD8,078,000USD13,847,000USD-737,000USD
    Total Cash From Operating Activities33,279,000USD-28,496,000USD-180,147,000USD-319,155,000USD-190,434,000USD-93,128,000USD-18,728,000USD
    Capital Expenditures-19,017,000USD-5,491,000USD-5,711,000USD-14,322,000USD-20,786,000USD-31,974,000USD-15,456,000USD
    Free Cash Flow14,262,000USD-33,987,000USD-185,858,000USD-333,477,000USD-211,220,000USD-125,102,000USD-34,184,000USD
    Investments-9,644,000USD-30,132,000USD-41,700,000USD-141,326,000USD-20,786,000USD-31,974,000USD-15,456,000USD
    Total Cashflows From Investing Activities-61,517,000USD-30,132,000USD-43,726,000USD-141,326,000USD-20,786,000USD-31,974,000USD-15,456,000USD
    Net Borrowings-3,662,000USD-3,225,000USD42,951,000USD-3,292,000USD-13,469,000USD11,732,000USD-1,709,000USD
    Total Cash From Financing Activities48,025,000USD44,162,000USD186,238,000USD197,315,000USD493,729,000USD129,056,000USD148,012,000USD
    Issuance Of Capital Stock46,704,000USD46,496,000USD-54,657,000USD-152,341,000USD442,684,000USD117,324,000USD118,824,000USD
    Change In Cash19,787,000USD-14,466,000USD-37,722,000USD-263,166,000USD282,509,000USD3,954,000USD113,828,000USD
    Begin Period Cash Flow86,202,000USD100,668,000USD137,403,000USD401,469,000USD118,960,000USD115,006,000USD1,178,000USD
    End Period Cash Flow105,989,000USD86,202,000USD99,681,000USD138,303,000USD401,469,000USD118,960,000USD115,006,000USD
    Other Cashflows From Financing Activities48,025,000USD891,000USD285,000USD2,948,000USD64,514,000USD117,324,000USD149,721,000USD
    Unclassified Investing Cash Flow-32,856,000USD5,491,000USD3,685,001USD148,492,000USD32,172,000USD39,854,000USD15,456,000USD
    Unclassified Financing Cash Flow-43,042,000USD—197,659,000USD-2,948,000USD—-117,324,000USD-118,824,000USD
    Other Cashflows From Investing Activities——-1USD-134,170,000USD-11,386,000USD-7,880,000USD—
    Change To Liabilities———14,992,000USD24,606,000USD14,246,000USD15,189,000USD
    Sale Purchase Of Stock———200,607,000USD———
    Cash And Cash Equivalents Changes———-263,166,000USD———
    Unclassified Operating Cash Flow———-49,124,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductDiagnostic Test Institutional Customers16,118,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDiagnostic Test Self Pay1,042,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDiagnostic Test Third Party Insurance94,726,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct And Service Other2,554,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductDiagnostic Test Institutional Customers16,094,000USD0001818331-26-000041
    Q1 2026Quarterly · 2026-03-31ProductDiagnostic Test Self Pay286,000USD0001818331-26-000041
    Q1 2026Quarterly · 2026-03-31ProductDiagnostic Test Third Party Insurance84,919,000USD0001818331-26-000041
    Q1 2026Quarterly · 2026-03-31ProductProduct And Service Other955,000USD0001818331-26-000041
    Q1 2026Quarterly · 2026-03-31SegmentAll Other Segments758,000USD0001818331-26-000041
    Q1 2026Quarterly · 2026-03-31SegmentGene Dx101,496,000USD0001818331-26-000041
    Q4 2025Quarterly · 2025-12-31ProductDiagnostic Test Institutional Customers16,214,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductDiagnostic Test Self Pay297,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductDiagnostic Test Third Party Insurance101,052,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct And Service Other3,426,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentAll Other Segments1,497,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentGene Dx119,492,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductDiagnostic Test Institutional Customers70,072,000USD0001818331-26-000015
    FY 2025Yearly · 2025-12-31ProductDiagnostic Test Self Pay1,361,000USD0001818331-26-000015
    FY 2025Yearly · 2025-12-31ProductDiagnostic Test Third Party Insurance345,235,000USD0001818331-26-000015
    FY 2025Yearly · 2025-12-31ProductProduct And Service Other10,871,000USD0001818331-26-000015
    FY 2025Yearly · 2025-12-31SegmentAll Other Segments4,451,000USD0001818331-26-000015
    FY 2025Yearly · 2025-12-31SegmentGene Dx423,088,000USD0001818331-26-000015
    Q3 2025Quarterly · 2025-09-30ProductDiagnostic Test Institutional Customers17,874,000USD0001818331-25-000130
    Q3 2025Quarterly · 2025-09-30ProductDiagnostic Test Self Pay629,000USD0001818331-25-000130
    Q3 2025Quarterly · 2025-09-30ProductDiagnostic Test Third Party Insurance95,020,000USD0001818331-25-000130
    Q3 2025Quarterly · 2025-09-30ProductProduct And Service Other3,220,000USD0001818331-25-000130
    Q3 2025Quarterly · 2025-09-30SegmentGene Dx114,697,000USD0001818331-25-000130
    Q3 2025Quarterly · 2025-09-30SegmentLegacy Sema42,046,000USD0001818331-25-000130
    Q2 2025Quarterly · 2025-06-30ProductDiagnostic Test Institutional Customers18,380,000USD0001818331-25-000108
    Q2 2025Quarterly · 2025-06-30ProductDiagnostic Test Self Pay339,000USD0001818331-25-000108
    Q2 2025Quarterly · 2025-06-30ProductDiagnostic Test Third Party Insurance81,104,000USD0001818331-25-000108
    Q2 2025Quarterly · 2025-06-30ProductProduct And Service Other2,869,000USD0001818331-25-000108
    Q2 2025Quarterly · 2025-06-30SegmentGene Dx101,784,000USD0001818331-25-000108
    Q2 2025Quarterly · 2025-06-30SegmentLegacy Sema4908,000USD0001818331-25-000108
    Q1 2025Quarterly · 2025-03-31ProductDiagnostic Test Institutional Customers17,604,000USD0001818331-26-000041
    Q1 2025Quarterly · 2025-03-31ProductDiagnostic Test Self Pay96,000USD0001818331-26-000041
    Q1 2025Quarterly · 2025-03-31ProductDiagnostic Test Third Party Insurance68,059,000USD0001818331-26-000041
    Q1 2025Quarterly · 2025-03-31ProductProduct And Service Other1,356,000USD0001818331-26-000041
    Q1 2025Quarterly · 2025-03-31SegmentAll Other Segments0USD0001818331-26-000041
    Q1 2025Quarterly · 2025-03-31SegmentGene Dx87,115,000USD0001818331-26-000041
    Q4 2024Quarterly · 2024-12-31ProductDiagnostic Test Institutional Customers14,331,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductDiagnostic Test Self Pay600,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductDiagnostic Test Third Party Insurance79,265,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct And Service Other1,444,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentAll Other Segments354,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentGene Dx95,286,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductDiagnostic Test Institutional Customers65,115,000USD0001818331-26-000015
    FY 2024Yearly · 2024-12-31ProductDiagnostic Test Self Pay2,343,000USD0001818331-26-000015
    FY 2024Yearly · 2024-12-31ProductDiagnostic Test Third Party Insurance234,699,000USD0001818331-26-000015
    FY 2024Yearly · 2024-12-31ProductProduct And Service Other3,293,000USD0001818331-26-000015
    FY 2024Yearly · 2024-12-31SegmentAll Other Segments3,157,000USD0001818331-26-000015
    FY 2024Yearly · 2024-12-31SegmentGene Dx302,293,000USD0001818331-26-000015
    Q3 2024Quarterly · 2024-09-30ProductDiagnostic Test Institutional Customers17,415,000USD0001818331-25-000130
    Q3 2024Quarterly · 2024-09-30ProductDiagnostic Test Self Pay460,000USD0001818331-25-000130
    Q3 2024Quarterly · 2024-09-30ProductDiagnostic Test Third Party Insurance59,543,000USD0001818331-25-000130
    Q3 2024Quarterly · 2024-09-30ProductProduct And Service Other-544,000USD0001818331-25-000130
    Q3 2024Quarterly · 2024-09-30SegmentGene Dx76,622,000USD0001818331-25-000130
    Q3 2024Quarterly · 2024-09-30SegmentLegacy Sema4252,000USD0001818331-25-000130
    Q2 2024Quarterly · 2024-06-30SegmentGene Dx68,924,000USD0001818331-25-000108
    Q2 2024Quarterly · 2024-06-30SegmentLegacy Sema41,590,000USD0001818331-25-000108
    FY 2023Yearly · 2023-12-31ProductDiagnostic Test Institutional Customers59,497,000USD0001818331-26-000015
    FY 2023Yearly · 2023-12-31ProductDiagnostic Test Self Pay1,666,000USD0001818331-26-000015
    FY 2023Yearly · 2023-12-31ProductDiagnostic Test Third Party Insurance134,491,000USD0001818331-26-000015
    FY 2023Yearly · 2023-12-31ProductProduct And Service Other6,912,000USD0001818331-26-000015
    FY 2023Yearly · 2023-12-31SegmentAll Other Segments8,190,000USD0001818331-26-000015
    FY 2023Yearly · 2023-12-31SegmentGene Dx194,376,000USD0001818331-26-000015
    FY 2022Yearly · 2022-12-31ProductDiagnostic Test Institutional Customers46,124,000USD0001818331-24-000008
    FY 2022Yearly · 2022-12-31ProductDiagnostic Test Self Pay7,586,000USD0001818331-24-000008
    FY 2022Yearly · 2022-12-31ProductDiagnostic Test Third Party Insurance173,624,000USD0001818331-24-000008
    FY 2022Yearly · 2022-12-31ProductProduct And Service Other7,360,000USD0001818331-24-000008
    FY 2022Yearly · 2022-12-31SegmentGene Dx122,234,000USD0001818331-24-000008
    FY 2022Yearly · 2022-12-31SegmentLegacy Sema4112,460,000USD0001818331-24-000008
    FY 2021Yearly · 2021-12-31ProductDiagnostic Test Institutional Customers31,717,000USD0001818331-23-000024
    FY 2021Yearly · 2021-12-31ProductDiagnostic Test Self Pay3,807,000USD0001818331-23-000024
    FY 2021Yearly · 2021-12-31ProductDiagnostic Test Third Party Insurance169,576,000USD0001818331-23-000024
    FY 2021Yearly · 2021-12-31ProductProduct And Service Other7,095,000USD0001818331-23-000024
    FY 2020Yearly · 2020-12-31ProductDiagnostic Test Institutional Customers35,200,000USD0001818331-23-000024
    FY 2020Yearly · 2020-12-31ProductDiagnostic Test Self Pay1,998,000USD0001818331-23-000024
    FY 2020Yearly · 2020-12-31ProductDiagnostic Test Third Party Insurance138,153,000USD0001818331-23-000024
    FY 2020Yearly · 2020-12-31ProductProduct And Service Other3,971,000USD0001818331-23-000024
    FY 2019Yearly · 2019-12-31ProductDiagnostic Test Institutional Customers20,888,000USD0001818331-22-000037
    FY 2019Yearly · 2019-12-31ProductDiagnostic Test Self Pay1,241,000USD0001818331-22-000037
    FY 2019Yearly · 2019-12-31ProductDiagnostic Test Third Party Insurance169,538,000USD0001818331-22-000037
    FY 2019Yearly · 2019-12-31ProductProduct And Service Other4,507,000USD0001818331-22-000037

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.